Literature DB >> 7033373

NK cell sensitivity of the leukemic K 562 cells; effect of sodium butyrate and hemin induction.

M C Dokhelar, U Testa, W Vainchenker, Y Finale, C Tetaud, P Salem, T Tursz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7033373

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

Review 1.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.

Authors:  M Vilien; M Troye-Blomberg; P Perlmann; H Wolf; F Rasmussen
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Adriamycin induced resistance of sensitive K 562 cells to natural killer lymphocyte attack.

Authors:  H Benoist; C Madoulet; J C Jardillier; A Desplaces
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.

Authors:  P Correale; A Procopio; L Celio; M Caraglia; G Genua; V Coppola; S Pepe; N Normanno; I Vecchio; G Palmieri
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.

Authors:  M Amar; N Amit; C Babin-Chevaye; T P Huu; J Hakim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

6.  NK-mediated reduction of malignancy in human melanoma cells treated with theophylline.

Authors:  I Gitelman; W Abramow-Newerly; J C Roder
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

7.  Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer.

Authors:  H Benoist; L Comoe; P Joly; Y Carpentier; A Desplaces; J Dufer
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation.

Authors:  B M Ohlsson-Wilhelm; B A Farley; B Kosciolek; S La Bella; P T Rowley
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

Review 9.  Therapeutic use of Aldara in chronic myeloid leukemia.

Authors:  Annette M Marleau; Jeffrey H Lipton; Neil H Riordan; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-25       Impact factor: 5.531

10.  A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.

Authors:  Norbert Vey; Lionel Karlin; Sophie Sadot-Lebouvier; Florence Broussais; Dominique Berton-Rigaud; Jérôme Rey; Aude Charbonnier; Delphine Marie; Pascale André; Carine Paturel; Robert Zerbib; Jaafar Bennouna; Gilles Salles; Anthony Gonçalves
Journal:  Oncotarget       Date:  2018-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.